Filter
98
Text search:
Licensed
pharmaceutical
products
Featured
Recommendations
7
New Publications
17
Language
Document type
No document type
37
Studies & Reports
29
Guidelines
17
Manuals
8
Strategic & Response Plan
4
Fact sheets
2
Situation Updates
1
Countries / Regions
Kenya
6
Zimbabwe
5
Ghana
4
India
4
South Africa
4
Global
4
Senegal
3
Ethiopia
3
Botswana
3
Liberia
2
Philippines
2
Tanzania
2
Rwanda
2
Malawi
2
Sierra Leone
1
Nigeria
1
Uganda
1
Nepal
1
Syria
1
Cambodia
1
Sudan
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western and Central Europe
1
Africa
1
Gabon
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
48
Clinical Guidelines
7
Pharmacy & Technologies
7
Public Health
5
Women & Child Health
2
Key Resources
2
Toolboxes
Pharmacy
16
AMR
15
COVID-19
12
Mental Health
4
TB
4
NTDs
2
Natural Hazards
1
HIV
1
Global Health Education
1
Caregiver
1
Malaria
1
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
Drug Distribution and Control: Preparation and Handling
This Technical Assistance Bulletin is intended to assist pharmacists in the extemporaneous compounding of non-sterile drug products for individual patients. Included in this document is
...
Drug Distribution and Control: Preparation and Handling–Guidelines
Review 2008
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affor
...
USAID Senegal and Health in Africa (HIA) initiative of the World Bank Group engaged the Strengthening Health Outcomes through the Private Sector (SHOPS) project to conduct an assessment of the private health sector in Senegal. The assessment’s primary focus is family planning, and its secondary fo
...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight
...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Ph
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the f ...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used
...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
